Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A John Barrett
Susan Prockop
Catherine M Bollard

Showing results (1-10 of 468) with videos related to

Pageof 47
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 17, 2017
Virus-Specific T Cells: Broadening ApplicabilityA John Barrett, Susan Prockop, Catherine M Bollard
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 10, 2018
Reprint of: Virus-Specific T Cells: Broadening ApplicabilityA John Barrett, Susan Prockop, Catherine M Bollard
Hematology. American Society of Hematology. Education Program|February 20, 2015
Cytotoxic T lymphocytes for leukemia and lymphomaCatherine M Bollard, A John Barrett
Frontiers in Immunology|October 28, 2017
Virus-Specific T Cells for the Immunocompromised PatientAmy Houghtelin, Catherine M Bollard
Blood Advances|January 4, 2018
Developing T-cell therapies for lymphoma without receptor engineeringMelanie Grant, Catherine M Bollard
Blood|August 26, 2021
EBV+ lymphoproliferative diseases: opportunities for leveraging EBV as a therapeutic targetKeri Toner, Catherine M Bollard
Blood|July 23, 2013
Scouting out the neighborhood in AIDS-related lymphomaKieron Dunleavy, Catherine M Bollard
Hematology. American Society of Hematology. Education Program|December 10, 2017
Developing T-cell therapies for lymphoma without receptor engineeringMelanie Grant, Catherine M Bollard
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2013
Generation of tumor antigen-specific T cell lines from pediatric patients with acute lymphoblastic leukemia--implications for immunotherapyGerrit Weber, Ignazio Caruana, Rayne H Rouce, et al.
Expert Review of Hematology|April 6, 2012
Immunotherapy highlights from the 2011 meeting of the American Society of HematologyPatrick J Hanley, Catherine M Bollard
Pageof 47

Showing results (1-10 of 468) with videos related to

Sort By:
Pageof 47
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 17, 2017
Virus-Specific T Cells: Broadening ApplicabilityA John Barrett, Susan Prockop, Catherine M Bollard
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 10, 2018
Reprint of: Virus-Specific T Cells: Broadening ApplicabilityA John Barrett, Susan Prockop, Catherine M Bollard
Hematology. American Society of Hematology. Education Program|February 20, 2015
Cytotoxic T lymphocytes for leukemia and lymphomaCatherine M Bollard, A John Barrett
Frontiers in Immunology|October 28, 2017
Virus-Specific T Cells for the Immunocompromised PatientAmy Houghtelin, Catherine M Bollard
Blood Advances|January 4, 2018
Developing T-cell therapies for lymphoma without receptor engineeringMelanie Grant, Catherine M Bollard
Blood|August 26, 2021
EBV+ lymphoproliferative diseases: opportunities for leveraging EBV as a therapeutic targetKeri Toner, Catherine M Bollard
Blood|July 23, 2013
Scouting out the neighborhood in AIDS-related lymphomaKieron Dunleavy, Catherine M Bollard
Hematology. American Society of Hematology. Education Program|December 10, 2017
Developing T-cell therapies for lymphoma without receptor engineeringMelanie Grant, Catherine M Bollard
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2013
Generation of tumor antigen-specific T cell lines from pediatric patients with acute lymphoblastic leukemia--implications for immunotherapyGerrit Weber, Ignazio Caruana, Rayne H Rouce, et al.
Expert Review of Hematology|April 6, 2012
Immunotherapy highlights from the 2011 meeting of the American Society of HematologyPatrick J Hanley, Catherine M Bollard
Pageof 47